The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
Market view
infliximab-dyyb · Injection
5 marketed package NDCs · 2 active manufacturers
Most dispensed: INFLIXIMAB 100 mg/10mL · Injection, Powder, Lyophilized, For Solution · #1 vial, single-use/carton / 10 ml in 1 vial, single-use · Kit · #1 kit/carton / 1 kit in 1 kit * 1 syringe in 1 tray / 1 ml in 1 syringe * 1 ml in 1 packet · Kit · #2 kits/carton / 1 kit in 1 kit * 1 syringe in 1 tray / 1 ml in 1 syringe * 1 ml in 1 packet · Kit · #4 kits/carton / 1 kit in 1 kit * 1 syringe in 1 tray / 1 ml in 1 syringe * 1 ml in 1 packet
What changed in the last 90 days
Every detected change for infliximab-dyyb, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- ZymfentraAug 12, 2026Mfr exitedCELLTRION USA Inc. · infliximab-dyyb
Same drug class
Other molecules FDA puts in Tumor Necrosis Factor Blocker, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Common questions
- Is Infliximab-dyyb in shortage right now?
- No. FDA does not currently list Infliximab-dyyb in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Infliximab-dyyb?
- 4 companies have marketed Infliximab-dyyb in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.